Limitation modification on optometrist prescribing and administering drugs

Minnesota Senate Bill SF850 proposes to expand the scope of practice for optometrists by modifying existing limitations on their ability to prescribe and administer certain medications. The bill allows optometrists to prescribe and administer legend drugs (prescription medications) for diagnosing and treating eye-related conditions, as taught in accredited optometry programs. However, it maintains specific restrictions to ensure patient safety: optometrists are prohibited from performing invasive surgeries, administering drugs intravenously, intramuscularly, or by injection (except in cases of anaphylaxis or specific eye-related injections), and prescribing certain medications without consulting a physician. For example, oral antivirals cannot be prescribed for more than ten days, and oral carbonic anhydrase inhibitors are limited to a seven-day prescription without physician consultation.

Supporters of SF850 argue that expanding optometrists' prescribing authority will improve patient access to timely eye care, especially in underserved areas. By allowing optometrists to manage a broader range of eye conditions, the bill is seen as a step toward more efficient and comprehensive eye health services. Proponents highlight that the bill includes safeguards, such as restrictions on certain drug administrations and mandatory physician consultations for specific prescriptions, to ensure patient safety.

Critics of SF850 express concerns about patient safety, questioning whether optometrists have sufficient medical training to prescribe and administer a wider range of medications. They worry that expanding optometrists' scope of practice could lead to misdiagnoses or inappropriate treatments. Additionally, some medical professionals argue that certain procedures and drug administrations should remain within the purview of ophthalmologists, who have more extensive medical education and surgical training.